Frequency Specific Microcurrent (FSM): The Complete Guide

High-tech skincare device setup for advanced microcurrent treatment in a clinic
Last Updated: April 22, 2026By Tags: ,

Frequency Specific Microcurrent (FSM) is a specialized branch of microcurrent therapy that pairs specific electromagnetic frequencies with specific tissues and conditions — using two channels simultaneously. It’s the most clinically developed frequency-specific modality in the microcurrent space, with published cytokine research, an Elsevier textbook, Cleveland Clinic recognition, and adoption by professional sports teams and military medical centers.

If you’ve read our microcurrent guide, you know that microcurrent in general delivers sub-milliamp electrical current to support cellular processes. FSM takes this a step further by proposing that which frequency you use matters as much as the current intensity — and that different frequencies resonate with different body tissues and different pathological conditions.

This guide covers how FSM works, its origins, the science behind it, what it’s used for, how it compares to standard microcurrent and TENS, and what to expect from a treatment session. We’ll be honest about what’s well-supported and where the evidence is still developing.

What makes FSM different from standard microcurrent

Standard microcurrent therapy delivers sub-milliamp current (typically 10–600 microamperes) to injured or affected tissue. The current itself — regardless of frequency — has been shown to increase ATP production by up to 500% in the foundational Cheng 1982 study. Most microcurrent devices use a single channel at a single frequency or a limited set of preset programs.

FSM differs in three fundamental ways:

The three pillars of FSM

1. Two simultaneous channels. FSM devices run two independent frequencies at the same time. Channel A delivers a frequency intended to address the condition (e.g., inflammation, scar tissue, mineral deposits). Channel B delivers a frequency intended to target the tissue (e.g., nerve, muscle, fascia, disc, tendon). This “condition + tissue” pairing is the defining feature of FSM and what separates it from all other microcurrent approaches.

2. Frequency specificity. FSM uses a catalog of over 200 frequencies, each associated with a specific tissue type or pathological condition. All frequencies are below 1,000 Hz. The specific frequency matters — practitioners report that one frequency combination may produce dramatic tissue changes while a nearly identical combination produces nothing. This is consistent with the concept of biological resonance.

3. Diagnosis-driven protocols. Unlike preset device programs, FSM protocols are selected based on clinical assessment. The practitioner must identify the actual tissue and condition involved — not just the symptom. FSM practitioners often say “the frequencies either work or don’t work,” and when they don’t, it typically means the diagnosis needs refining rather than the treatment being ineffective.

The origin story: lost frequencies rediscovered

FSM has one of the more interesting origin stories in frequency wellness technology.

In the early 1900s — before antibiotics and before the FDA existed in its current form — physicians and osteopaths routinely used electromagnetic frequency devices to treat patients. These devices delivered specific frequencies on one or two channels, with published frequency lists pairing conditions and tissues. Thousands of practitioners used these devices, and research was shared through medical journals and conferences.

In 1934, the AMA began cracking down on electromagnetic therapies, and most of this knowledge was abandoned. But not all of it was lost.

In 1946, an osteopath and naturopath named Harry VanGelder purchased a practice in Vancouver, Canada, that came with an unusual device built in 1922 — and a list of frequencies. VanGelder used the device for decades. In 1983, his associate George Douglas brought home a copy of the frequency list and put it in a drawer, where it remained forgotten for over a decade.

In 1995, Dr. Carolyn McMakin — a chiropractor and naturopathic physician in Portland, Oregon — received that frequency list from Douglas and began systematically testing the frequencies with a modern two-channel microcurrent device. She spent 1995–1996 conducting blinded treatments on volunteers to establish safety and reproducibility. When she first taught the method in January 1997, she wanted to determine whether results were placebo or real. By June 1997, practitioners across the country were independently reproducing her clinical observations.

Dr. McMakin has since published multiple peer-reviewed papers, authored the definitive textbook (Frequency Specific Microcurrent in Pain Management, Elsevier, 2010), and a popular book (The Resonance Effect, North Atlantic Books/Penguin Random House, 2017). She continues treating patients four days a week at her clinic in Troutdale, Oregon, and has trained thousands of practitioners worldwide through the FSM Core and Advanced seminars.

How the two-channel system works

The two-channel paradigm is FSM’s most distinctive and most important feature. Understanding it is essential to understanding why FSM produces different clinical effects than standard microcurrent.

Channel A — The condition frequency

This channel delivers a frequency associated with the pathological condition being addressed. Common condition frequencies target: inflammation, scar tissue/fibrosis, mineral deposits, toxicity, congestion, allergy reaction, and trauma. For example, 40 Hz is the frequency most associated with reducing inflammation — this specific frequency has been tested in both human and animal models.

Channel B — The tissue frequency

This channel delivers a frequency associated with the target tissue. Common tissue frequencies target: nerve (396 Hz), muscle, fascia, tendon, ligament, disc, spinal cord, joint capsule, bone, and specific organs. Each tissue type has its own designated frequency from the catalog.

The clinical insight: “Shoulder pain” isn’t a diagnosis — it’s a symptom. The actual problem could be nerve irritation, joint inflammation, muscle adhesions, tendon damage, or referred pain from elsewhere. In standard microcurrent, you apply current to the shoulder and hope for the best. In FSM, you test specific condition-tissue frequency pairs until you find the combination that produces a palpable tissue response. When the right pair is found, practitioners consistently report an immediate, measurable softening and warming of tissue.

This diagnostic feedback loop is part of what makes FSM both powerful and complex. The frequencies confirm or deny the practitioner’s assessment in real time — if the frequencies for “inflammation in the nerve” produce dramatic softening but “inflammation in the muscle” produces nothing, the practitioner knows the nerve — not the muscle — is the primary problem.

Technical delivery: FSM frequencies are delivered using a ramped square wave with alternating pulsed direct current at microamperage levels (typically 20–600 µA). The current is sub-sensory — patients cannot feel it. The frequencies are delivered through moistened towels, conductive graphite gloves, or gel electrode patches placed on the skin. Patient hydration is critical — dehydrated patients respond poorly because water is needed to conduct the current through tissues.

The science: what research shows

FSM’s research base is stronger than most frequency wellness modalities but weaker than established medical therapies. Here’s an honest assessment of the evidence hierarchy.

Published FSM-specific research

McMakin, Gregory & Phillips (2005) — Fibromyalgia cytokine study. Published in the Journal of Bodywork and Movement Therapies. In 54 patients with fibromyalgia associated with cervical spine trauma, FSM treatment produced substantial reductions in inflammatory cytokines IL-1, IL-6, and TNF-α, and the pain neuropeptide substance P — all by factors of 10–20x within 90 minutes. Beta-endorphin and cortisol also increased. Limitation: This was a retrospective, uncontrolled study — not a randomized controlled trial. The cytokine changes are dramatic and difficult to explain by placebo, but the study design limits the strength of the conclusions.

Curtis, Fallows, Morris & McMakin (2010) — DOMS study. Published in the Journal of Bodywork and Movement Therapies. Examined FSM vs. sham treatment for delayed-onset muscle soreness. Found statistically significant protection from DOMS at 24h (treated: 1.3/10 vs. untreated: 5.2/10, p=0.0005), 48h, and 72h. Importantly: This study was designed to address the earlier Allen 1999 null finding with single-frequency microcurrent — and showed that the two-channel, frequency-specific approach produced dramatically different results.

Reilly, Reeve & McMakin (2004) — Mouse inflammation model. Blinded animal study at the University of Sydney demonstrating a 62% reduction in COX-mediated inflammation with a 4-minute, frequency-specific, time-dependent response. Animal studies eliminate placebo effects entirely.

McMakin (2004) — Chronic low back myofascial pain. Published in the Journal of Bodywork and Movement Therapies. Analysis of 22 patients with chronic low back pain (average 8.8 years duration) showing a 3.8-fold reduction in pain intensity over an average 5.6-week treatment period. In 90% of patients, other modalities (drugs, chiropractic, PT, acupuncture) had failed to produce equivalent benefits.

What the science doesn’t yet prove

No large-scale RCTs. The FSM-specific evidence consists of small studies, retrospective analyses, and case series. No multi-center randomized controlled trial has been published for FSM. This is the biggest gap.

The mechanism of frequency specificity remains theoretical. The concept that tissues resonate at specific electromagnetic frequencies is consistent with physics (resonance is well-established in other domains) but has not been proven at the cellular level for FSM frequencies specifically. The fact that changing a frequency by even a few hertz eliminates the clinical effect is compelling observational evidence but not mechanistic proof.

Most published research involves Dr. McMakin. While this reflects her role as the field’s pioneer, independent replication by unaffiliated research groups would significantly strengthen the evidence base.

For the broader microcurrent evidence base that underpins FSM, see our Microcurrent Research Reference: 60+ Studies Cited.

Conditions addressed by FSM

FSM is used most commonly in clinical settings for musculoskeletal and neurological conditions. The following are the areas where FSM has the strongest practitioner consensus and/or published support:

Strongest evidence

Fibromyalgia (cervical trauma-associated), myofascial pain, DOMS/muscle recovery, chronic low back pain, neuropathic pain, scar tissue/adhesions, nerve pain, inflammation reduction

Strong clinical consensus

Shingles pain, tendinopathies, disc injuries, post-surgical recovery, concussion/TBI, wound healing, burn recovery, facet joint pain

Emerging applications

Vagus nerve dysfunction, visceral conditions, chronic fatigue, liver enzyme reduction, emotional trauma patterns, autoimmune support

Cleveland Clinic’s page on FSM notes that it “most often treats musculoskeletal conditions in physical therapy settings” and “can help with pain management and recovery from acute and chronic injuries and pain conditions.” Cleveland Clinic categorizes FSM as complementary medicine — not a primary treatment, but potentially valuable alongside conventional care.

FSM protocols were used at the National Intrepid Center of Excellence at Walter Reed National Military Medical Center for post-concussion patients — a significant institutional endorsement from the military medical establishment.

What to expect in an FSM session

A typical clinical FSM session lasts 60–90 minutes. Here’s the general flow:

1. Assessment. The practitioner takes a detailed history and performs a physical examination. In FSM, accurate diagnosis is everything — the frequencies only work when matched to the actual tissue and condition involved. The practitioner identifies what tissues are affected and what pathological processes are at play.

2. Hydration check. You’ll be asked to drink water before the session. FSM requires adequate tissue hydration to conduct the current effectively. Dehydrated patients respond poorly.

3. Contact placement. The practitioner applies moistened towels, conductive graphite gloves, or gel electrode patches to your skin. Placement depends on the target tissues and the current pathway needed.

4. Frequency protocol. The practitioner programs condition-tissue frequency pairs into the dual-channel device and runs them in sequence. They palpate your tissues continuously, feeling for the characteristic softening and warming that indicates the correct frequency has been found.

5. During treatment. You won’t feel the current — it’s sub-sensory. Many patients report feeling relaxed, warm, or slightly “floaty.” Some experience a dramatic, immediate reduction in pain. Others notice effects developing over hours or days after the session.

6. Post-treatment. Some patients feel mildly fatigued or experience temporary nausea or drowsiness — similar to post-massage detox reactions. These symptoms typically resolve within 24 hours. Increased water intake is recommended after treatment.

FSM vs. TENS vs. standard microcurrent

These three electrical modalities are often confused. Here’s how they differ:

TENS (Transcutaneous Electrical Nerve Stimulation) operates in the milliamp range — 1,000x stronger than microcurrent. It works by overwhelming sensory nerves to block pain signals (gate control theory). You can feel it; it causes muscle contraction. TENS provides temporary pain relief but doesn’t promote cellular healing. Most effects end when the device is turned off.

Standard microcurrent operates in the microamp range (10–600 µA). It’s sub-sensory — you can’t feel it. It increases ATP production and supports cellular healing processes. Most standard microcurrent devices use a single channel with limited frequency options or preset programs. Devices like the Healy fall in this category.

FSM operates at the same microamp level as standard microcurrent but uses two independent channels delivering specific frequency pairs targeted to the diagnosed condition and tissue. The dual-channel, condition-tissue paradigm is unique to FSM. Practitioners report that the specificity produces effects that standard single-channel microcurrent does not — supported by the Curtis 2010 study showing FSM succeeded where single-frequency microcurrent failed for DOMS.

For a deeper dive into how microcurrent compares to other frequency modalities, see our 5 Types of Frequency Technology guide.

Home use vs. clinical treatment

FSM was designed as a clinical modality requiring trained practitioners. However, home-use options exist:

Clinical treatment is recommended for initial assessment, acute conditions, and complex cases. A trained practitioner can test frequency combinations in real time, adjust protocols based on tissue response, and address the diagnostic complexity that FSM requires. Session costs typically range from $75–$200 depending on the practitioner and location. To find a trained FSM practitioner, the official directory is available at frequencyspecific.com.

Home units are available — typically automated devices pre-programmed with common FSM protocols. These are simpler to use but less flexible than clinical devices. Home units work best for maintenance treatment of already-diagnosed conditions, DOMS/athletic recovery protocols, and general wellness support. They are not a substitute for clinical assessment and treatment of complex or acute conditions. Any dual-channel microcurrent device that can deliver three-digit specific frequencies (e.g., 284 Hz rather than 280 Hz) on each channel using a ramped square wave is technically capable of running FSM protocols.

Important note: FSM seminars teach frequency protocols and biological resonance principles — they do not sell or promote specific devices. The research and publications use devices manufactured by Precision Microcurrent Inc., but FSM’s value is in the frequency knowledge, not any particular hardware.

Safety and contraindications

FSM has a strong safety profile. The current levels used (microamperes) are approximately equal to the body’s own endogenous bioelectric currents, making adverse reactions extremely rare. The most common side effects are mild and transient: temporary fatigue, nausea, or drowsiness — similar to detox reactions from massage therapy.

Who should NOT use FSM

People with pacemakers or implanted electrical devices — any external electromagnetic stimulation could theoretically interfere with implanted devices.

People with implanted pumps — same concern as pacemakers regarding electromagnetic interference.

Pregnant women — not because harm has been observed, but because no studies have been conducted. This is a caution-based recommendation, not an evidence-based one.

People with uncontrolled seizures — electrical stimulation could theoretically lower seizure threshold.

Cancer patients — this is a conservative recommendation. The concern is that increased ATP production and cellular metabolism could theoretically accelerate tumor growth. No negative effects have been documented, but prudence is warranted.

Additionally, specific scar-tissue-dissolving frequencies should not be used within 6 weeks of a new injury, as the body needs initial scar formation for structural stability during early healing.

For a broader discussion of frequency device safety, see our complete safety guide.

The honest assessment

FSM sits in an unusual position in the wellness technology landscape. It has more published clinical evidence than most frequency modalities, genuine institutional adoption (Cleveland Clinic, Walter Reed, professional sports), and a rigorous practitioner training system. The cytokine data from the fibromyalgia study is particularly striking — inflammatory markers dropping by 10–20x in 90 minutes is difficult to explain by placebo alone.

At the same time, the evidence base has meaningful gaps. The published studies are small, most involve Dr. McMakin, and no large multi-center RCTs exist. The theoretical mechanism (biological resonance at specific frequencies) is plausible but unproven at the molecular level. And the origin of the frequency list — a 1922 device from an osteopath’s practice — invites skepticism from conventionally trained physicians.

Our bottom line on FSM

FSM is the most clinically developed frequency-specific modality available today. For patients with conditions that have resisted conventional treatment — particularly chronic pain, fibromyalgia, neuropathic pain, and persistent soft tissue injuries — FSM represents a low-risk option worth exploring with a trained practitioner.

The best approach: find a trained FSM practitioner through the official directory, try 2–3 clinical sessions for your specific condition, and evaluate your response. FSM’s effects are typically apparent quickly — if the right frequencies exist for your condition, you should notice changes within the first few sessions.

FSM is not a replacement for conventional medical care. It works best as a complement to — not a substitute for — proper medical diagnosis and treatment. But for the “impossible cases” that walk through every practitioner’s door, it offers a tool that didn’t exist before.

Disclaimer: This article is an educational guide about Frequency Specific Microcurrent technology. It does not constitute medical advice and is not intended to diagnose, treat, cure, or prevent any disease. FSM devices are FDA-cleared in the category of TENS devices for pain management; the specific frequencies and their clinical applications have not been evaluated by the FDA. Results vary by individual and condition. Always consult a qualified healthcare practitioner before beginning any new wellness practice. FSM should be administered by licensed healthcare practitioners trained in its application. Frequency Tech is an independent review site — see our Affiliate Disclosure for our policies on device manufacturer relationships.